Q30 Innovations Requests FDA Authorization for the Q-Collar

Q30 Innovations Requests FDA Authorization for the Q-Collar

05.14.2020

After eight years of scientific research and clinical trials, Q30 Innovations announced that it has submitted a request for De Novo classification to the U.S. Food and Drug Administration, seeking authorization to market the Q-CollarĀ  in the United States.

Read the full article on Yahoo.

Comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *

*